MAXYGEN

Mar 11, 08
	NEW STORY
09:00 ET	Maxygen to Present at the Cowen & Company 28th Annual Health Care Conference
Mar 04, 08
09:00 ET	Maxygen Announces Management Changes
Feb 12, 08
09:00 ET	Maxygen Reports Fourth Quarter and Year End 2007 Financial Results
Feb 11, 08
16:08 ET	Maxygen to Present at the Roth 20th Annual OC Growth Stock Conference
Jan 29, 08
09:00 ET	Maxygen to Host Fourth Quarter and Year End 2007 Financial Results Conference Call on February 12, 2008
Jan 11, 08
09:00 ET	Maxygen to Present at the Stanford Group Company 13th Annual Healthcare Conference
Jan 07, 08
09:00 ET	Maxygen Announces Positive Progress in Phase IIa Clinical Trial of Novel PEG-GCSF
Dec 28, 07
09:00 ET	Maxygen to Present at the JPMorgan 26th Annual Healthcare Conference
Dec 04, 07
09:00 ET	Maxygen Licenses Dengue Vaccine Technology to sanofi pasteur
Nov 27, 07
09:00 ET	Maxygen Announces Plans to Consolidate Operations in the U.S.
Nov 26, 07
09:00 ET	Maxygen Updates Status of MAXY-alpha Program
Nov 19, 07
09:00 ET	Maxygen to Receive $7 Million From BioFuel Collaboration Between Shell and Codexis
Nov 01, 07
09:00 ET	Maxygen Reports Third Quarter 2007 Financial Results
Oct 25, 07
09:00 ET	Maxygen Announces Upcoming Webcasts at Investor Conferences
Oct 19, 07
09:00 ET	Maxygen Third Quarter 2007 Financial Results Conference Call Notice
Sep 21, 07
08:00 ET	Maxygen Announces Hold on MAXY-alpha Development Program
Sep 18, 07
09:00 ET	Maxygen to Present at the 2007 UBS Global Life Sciences Conference
Aug 02, 07
09:00 ET	Maxygen Reports Second Quarter 2007 Financial Results
Jul 17, 07
09:00 ET	Maxygen Second Quarter 2007 Financial Results Conference Call Notice
Jul 02, 07
09:00 ET	Maxygen Initiates Phase IIa Clinical Trial of MAXY-G34 in Breast Cancer Patients
Jun 05, 07
09:00 ET	Maxygen to Present at the Goldman Sachs 28th Annual Global Healthcare Conference
May 16, 07
17:13 ET	Maxygen Files Universal Shelf Registration Statement
May 14, 07
09:00 ET	Maxygen Added to NASDAQ Biotechnology Index
May 08, 07
09:00 ET	Maxygen Reports First Quarter 2007 Financial Results
May 03, 07
08:00 ET	Maxygen to Present at the Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference
Apr 25, 07
09:00 ET	Maxygen First Quarter 2007 Financial Results Conference Call Notice
Apr 10, 07
07:00 ET	Maxygen to Present Review of G-CSF Clinical Program Live at NASDAQ MarketSite(R) Tuesday, April 17, 8:00 a.m. EDT
Mar 13, 07
16:00 ET	Maxygen Announces End of Co-Development Agreement
Mar 06, 07
07:00 ET	Maxygen to Present at the Cowen and Company 17th Annual Health Care Conference
Feb 21, 07
07:00 ET	Maxygen Appoints Santosh Vetticaden, M.D., Ph.D., as Chief Medical Officer
Feb 06, 07
07:00 ET	Maxygen Reports Fourth Quarter and Year End 2006 Financial Results
Jan 29, 07
09:00 ET	Maxygen to Host Fourth Quarter and Year End 2006 Financial Results Conference Call on February 6, 2007
Dec 05, 06
07:00 ET	Maxygen Announces Grant of Biofuels License to Codexis, Inc.
Nov 07, 06
07:00 ET	Maxygen's Next-Generation Interferon Alpha Enters Phase Ia Clinical Trial
Nov 01, 06
07:00 ET	Maxygen to Present at the Rodman & Renshaw 8th Annual Healthcare Conference and the ThinkEquity ThinkTank Summit
Oct 30, 06
07:00 ET	Maxygen Reports Third Quarter 2006 Financial Results
Oct 27, 06
15:15 ET	Maxygen to Receive $17.8 Million From Acquisition of Avidia by Amgen
Oct 24, 06
16:30 ET	Maxygen to Host Third Quarter 2006 Financial Results Conference Call on October 30, 2006
Sep 20, 06
07:00 ET	Maxygen to Present at the UBS 2006 Global Life Sciences Conference
Sep 05, 06
07:00 ET	Maxygen Initiates Phase I Clinical Trial for Maxy-G34
Jul 31, 06
07:00 ET	Maxygen Reports Second Quarter 2006 Financial Results
Jul 18, 06
18:00 ET	Maxygen to Host Second Quarter 2006 Financial Results Conference Call on July 31, 2006
Jun 07, 06
17:02 ET	Maxygen to Present at the Goldman Sachs Healthcare Conference
May 10, 06
19:00 ET	Maxygen to Present at the Rodman and Renshaw 3rd Annual Healthcare Conference
May 09, 06
07:00 ET	Maxygen Achieves Milestone in Alliance with Roche for Factor VIIa Therapeutics
Apr 25, 06
07:00 ET	Maxygen Reports First Quarter 2006 Financial Results
Apr 19, 06
16:00 ET	Maxygen to Host First Quarter 2006 Financial Results Conference Call on April 25, 2006
Mar 01, 06
16:01 ET	Maxygen to Present at the Cowen & Co. 26th Annual Health Care Conference and the Lehman Brothers Ninth Annual Global Healthcare Conference
Feb 08, 06
16:02 ET	Maxygen to Present at the BIO CEO & Investor Conference
07:02 ET	Maxygen Reports Fourth Quarter and Year End 2005 Financial Results
Jan 30, 06
16:08 ET	Maxygen to Host Fourth Quarter and Year End 2005 Financial Results Conference Call on February 8, 2006
Jan 05, 06
16:00 ET	Maxygen to Present at the JPMorgan 24th Annual Healthcare Conference
Dec 20, 05
04:00 ET	Maxygen Announces Management Changes
Dec 15, 05
01:30 ET	Roche and Maxygen to Co-Develop Recombinant Factor VIIa Therapeutics for Acute Bleeding
Dec 14, 05
14:00 ET	Maxygen to Host 2005 Year End Conference Call on December 15, 2005
07:30 ET	Maxygen Announces Achievement of Milestone in Roche Alliance
Dec 09, 05
16:00 ET	Maxygen Appoints Louis G. Lange to Its Board of Directors
Nov 01, 05
16:00 ET	Maxygen to Present at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference
Oct 25, 05
07:06 ET	Maxygen Reports Third Quarter 2005 Financial Results
Oct 20, 05
16:00 ET	Maxygen Announces $14.4 Million in U.S. Government Funding to Advance HIV Vaccine Research
Oct 17, 05
17:52 ET	Maxygen to Host Third Quarter 2005 Earnings Conference Call on October 25, 2005
Sep 26, 05
16:45 ET	Maxygen, Inc. Announces Change to Presentation Time at the 2005 UBS Global Life Sciences Conference
Sep 22, 05
16:00 ET	Maxygen, Inc. Announces Webcast of Presentation at the UBS 2005 Global Life Sciences Conference
Jul 26, 05
07:00 ET	Maxygen Reports Second Quarter 2005 Financial Results
Jul 19, 05
19:30 ET	Maxygen to Host Second Quarter 2005 Earnings Conference Call on July 26, 2005
Jun 16, 05
20:00 ET	Maxygen Consolidates to Focus Resources on Product Development
Jun 09, 05
07:00 ET	Maxygen, Inc. Announces Webcast of Corporate Presentation at the Goldman Sachs 26th Annual Global Healthcare Conference
Apr 28, 05
08:05 ET	Maxygen, Inc. Announces Webcast of Presentation at the Rodman & Renshaw Techvest Global Healthcare Conference
Apr 26, 05
07:04 ET	Maxygen Reports First Quarter 2005 Financial Results
Apr 14, 05
08:00 ET	Maxygen to Host First Quarter 2005 Earnings Conference Call on April 26, 2005
Mar 30, 05
08:01 ET	Maxygen Announces Achievement of Milestone in Alliance with Roche
Mar 28, 05
16:00 ET	Maxygen, Inc. Announces Webcast of Corporate Presentation at the Lehman Brothers Eighth Annual Global Healthcare Conference
Mar 08, 05
20:00 ET	Maxygen, Inc. Announces Webcast of Corporate Presentation at the JP Morgan Small Cap Conference
Feb 18, 05
08:02 ET	Maxygen, Inc. Announces Webcast of Corporate Presentation at the BIO CEO & Investor Conference
Feb 08, 05
07:02 ET	Maxygen Reports Fourth Quarter and Year End 2004 Financial Results
Feb 02, 05
16:02 ET	Maxygen to Host Fourth Quarter and Year End 2004 Earnings Conference Call on February 8, 2005
Jan 06, 05
16:00 ET	Maxygen to Webcast Presentation at the 23rd Annual JP Morgan Healthcare Conference
Dec 03, 04
20:15 ET	Maxygen Announces New Development Program and Product Development Prioritization
Oct 26, 04
07:01 ET	Maxygen Reports Third Quarter 2004 Financial Results
Oct 25, 04
12:50 ET	Maxygen to Webcast Presentation at the Rodman and Renshaw Techvest 6th Annual Healthcare Conference
Oct 19, 04
17:53 ET	Maxygen to Webcast Third Quarter 2004 Earnings Conference Call on October 26, 2004
Oct 11, 04
19:03 ET	Maxygen to Webcast Presentation at the BIO Emerging Company Investor Forum Conference
Sep 21, 04
10:58 ET	Maxygen to Webcast Presentation at the UBS Global Life Sciences Conference
Sep 09, 04
06:30 ET	Maxygen and Rentschler Sign Agreement to Manufacture Novel G-CSF
Jul 27, 04
07:34 ET	Maxygen Reports Second Quarter 2004 Financial Results
Jul 21, 04
17:00 ET	Maxygen to Webcast Second Quarter 2004 Earnings Conference Call on July 27, 2004
Jun 08, 04
05:00 ET	Maxygen and Biovitrum Sign Agreement to Manufacture Optimized Beta Interferon for Phase I and II Clinical Trials
Jun 02, 04
19:11 ET	Maxygen to Webcast Presentation at the Goldman Sachs 25th Annual Healthcare Conference
May 20, 04
14:00 ET	Maxygen Subsidiary Verdia Announces Discovery and Improvement of Glyphosate Tolerance Gene
Apr 27, 04
07:03 ET	Maxygen Reports First Quarter 2004 Financial Results and Progress of Product Pipeline
Apr 20, 04
17:19 ET	Maxygen to Webcast First Quarter 2004 Earnings Conference Call on April 27, 2004
Feb 23, 04
09:01 ET	Maxygen, Inc. Announces Webcast of Corporate Presentation at the 6th Annual BIO CEO & Investor Conference
Feb 10, 04
07:30 ET	Maxygen Reports Fourth Quarter and Year End 2003 Financial Results
Feb 03, 04
16:35 ET	Maxygen to Webcast Year-End 2003 Earnings Conference Call on February 10, 2004
Jan 13, 04
09:25 ET	Maxygen, Inc. Announces Webcast of Presentation at 22nd Annual JP Morgan Healthcare Conference
Oct 28, 03
07:32 ET	Maxygen Reports Third Quarter 2003 Financial Results
Oct 22, 03
09:00 ET	Maxygen Appoints James R. Sulat to Its Board of Directors
Oct 21, 03
20:11 ET	Maxygen to Webcast Third Quarter 2003 Earnings Conference Call on October 28, 2003
Sep 23, 03
12:30 ET	Maxygen, Inc. to Present at UBS Global Life Sciences Conference With Live Webcast
Jul 29, 03
06:01 ET	Maxygen Reports Second Quarter 2003 Financial Results
Jul 22, 03
17:02 ET	Maxygen to Webcast Second Quarter 2003 Earnings Conference Call On July 29, 2003
Jul 07, 03
08:01 ET	Maxygen Announces Alliance with Roche Completes Hart-Scott-Rodino Review
Jun 11, 03
16:11 ET	Maxygen to Webcast 2003 Annual Meeting of Stockholders on June 12, 2003
Jun 10, 03
16:05 ET	Maxygen, Inc. Announces Webcast of Presentation at Goldman Sachs Healthcare Conference
May 22, 03
02:00 ET	Maxygen to Webcast Conference Call to Discuss New Alliance with Roche
01:30 ET	Roche and Maxygen Establish Broad Alliance to Develop and Commercialize Next-Generation Interferon Alpha and Beta Products
Apr 29, 03
07:32 ET	Maxygen Reports Strong First Quarter 2003 Financial Results
Apr 24, 03
16:08 ET	Maxygen to Webcast First Quarter 2003 Earnings Conference Call on April 29, 2003
Mar 03, 03
18:00 ET	Maxygen Appoints Elliot P. Goldstein, M.D., Senior Vice President, Clinical Development and Denmark Operations
Feb 25, 03
13:32 ET	Maxygen Invites Investors to Listen to Webcast of Presentation at the BIO CEO & Investor Conference
Feb 24, 03
08:01 ET	Codexis Announces New Product Launched by Partner Novozymes
Feb 11, 03
07:30 ET	Maxygen Reports Strong Fourth Quarter and Year End 2002 Financial Results
Feb 04, 03
17:28 ET	Maxygen to Webcast Year-End 2002 Earnings Conference Call on February 11, 2003
Jan 06, 03
20:05 ET	Maxygen, Inc. Announces Webcast of Presentation at the 21st Annual JPMorgan H&Q Healthcare Conference
Dec 20, 02
02:38 ET	Codexis Announces Collaboration with Eli Lilly and Company for the Development Of Improved Fermentation Processes
Nov 13, 02
16:05 ET	Maxygen Increases Focus on Advancing Key Therapeutic Products And Reducing Costs
Oct 29, 02
09:01 ET	Maxygen Reports Third Quarter 2002 Financial Results
Oct 28, 02
09:00 ET	MaxyAg Announces Name Change to Verdia, Inc.
Oct 23, 02
18:30 ET	Maxygen to Webcast Third Quarter 2002 Earnings Conference Call on October 29
Oct 07, 02
07:00 ET	InterMune and Maxygen Announce Progress in Alliance to Develop Once-Weekly Actimmmune
Oct 04, 02
07:00 ET	Codexis Announces Closing of $25 Million Private Financing
Oct 01, 02
13:25 ET	Maxygen Announces Webcast of Presentation at UBS Warburg Fourth Annual Global Life Sciences Conference
Sep 24, 02
07:00 ET	Codexis Announces Commercialization Royalties in DSM Collaboration
Sep 19, 02
09:01 ET	Codexis Announces Appointment of John Grate as Vice President of R&D And Chief Technology Officer
07:00 ET	Maxygen Publishes Novel Approach to Regulation of the Human Immune Response
Sep 17, 02
07:01 ET	Codexis Announces Commercialization and Milestone Payments In Pfizer Collaboration
Aug 22, 02
16:00 ET	Maxygen Receives $2.4 Million Grant to Develop Cross Protective Vaccines
Jul 30, 02
07:01 ET	Maxygen Reports Second Quarter 2002 Financial Results
Jul 24, 02
13:19 ET	Maxygen Announces Appointment of Paul Spence, D.Phil., to Senior Vice President of Research and Development, Human Therapeutics
Jul 23, 02
21:32 ET	Maxygen to Webcast Second Quarter 2002 Earnings Conference Call on July 30, 2002
Jun 11, 02
07:32 ET	Codexis Delivers Second Milestone in DSM Alliance and Announces Extension of Collaboration
Jun 10, 02
19:13 ET	Maxygen Announces Webcast of Presentation at the Goldman Sachs 23rd Annual Global Healthcare Conference
May 30, 02
16:59 ET	Webcast Alert: Maxygen Announces Its Annual Stockholder Webcast Conference Call on the Web
May 28, 02
07:30 ET	Maxygen Announces Joint Venture With Delta and Pine Land Company to Develop Improved Cotton Seed Products
May 13, 02
08:31 ET	Maxygen Announces Major Advances in Its MolecularBreeding(TM) Product Discovery Platform
Apr 30, 02
06:00 ET	Maxygen Reports First Quarter 2002 Financial Results
Apr 23, 02
18:01 ET	Maxygen to Webcast First Quarter 2002 Earnings Conference Call On April 30, 2002
Apr 17, 02
06:04 ET	Codexis, Inc. and Cargill Dow Announce Collaboration to Improve Novel Process For NatureWorks(TM) PLA
Apr 09, 02
16:53 ET	Maxygen Granted U.S. Patent Covering Synthetic Gene Assembly Technologies
Feb 27, 02
07:01 ET	Codexis, a Wholly Owned Subsidiary of Maxygen, Appoints Industrial Advisory Board
Feb 26, 02
16:30 ET	Maxygen Announces Launch of Wholly Owned Chemicals Subsidiary Codexis, Inc.
Feb 21, 02
06:03 ET	Maxygen Announces Advancement of Improved Interferon Beta for Multiple Sclerosis
Feb 12, 02
06:00 ET	Maxygen Reports Fourth Quarter and Year End 2001 Financial Results
Feb 07, 02
17:54 ET	Maxygen's Whole Genome Shuffling Technologies Open New Product Areas In Fermentation and Vaccines
Feb 05, 02
16:30 ET	Maxygen to Webcast Year-End 2001 Financial Results Conference Call On February 12, 2002
Jan 08, 02
08:00 ET	Celltech and Maxygen Enter Into Antibody Collaboration
Jan 07, 02
09:01 ET	JP Morgan H&Q 20th Annual Healthcare Conference to Webcast Maxygen, Inc. Presentation
Nov 26, 01
07:00 ET	Maxygen Announces Issuance of Patent Covering Methods of Template-Based Recombination to Produce Chimeric Genes
Nov 13, 01
07:01 ET	Maxygen Reports Strong Third Quarter 2001 Financial and Operating Results
Nov 12, 01
18:00 ET	Maxygen Delivers Two Product Candidates for Development
09:00 ET	Novozymes and Maxygen Announce Advancement of Two Additional Product Candidates
Nov 08, 01
13:00 ET	Maxygen to Webcast Third Quarter 2001 Earnings Conference Call On November 13, 2001
Nov 07, 01
14:15 ET	Maxygen Reiterates Press Release and Makes Available Arbitration Award
Nov 05, 01
13:08 ET	Arbitrator Awards Maxygen Sweeping Remedies in Ruling Against Enchira Biotechnology
04:56 ET	Maxygen and Aventis Pasteur Enter Strategic Alliance to Develop Improved Vaccines
Oct 09, 01
14:34 ET	Maxygen Announces Advancement of Human Therapeutics Candidates
Oct 08, 01
16:00 ET	Maxygen Announces Grant of First European Patents
Oct 03, 01
09:01 ET	Maxygen Awarded $3.7 Million USAID Cooperative Grant to Develop Malaria Vaccine
Sep 26, 01
16:01 ET	Maxygen Appoints Alan Shaw, Ph.D., President of Chemicals Division
Sep 18, 01
17:00 ET	Maxygen Creates Novel Protein Activity for New Market Opportunities
Sep 05, 01
06:00 ET	InterMune and Maxygen Form Collaboration to Develop Next-Generation Interferon Gamma Products
Aug 14, 01
05:30 ET	Maxygen Reports Second Quarter 2001 Financial Results
Aug 08, 01
19:01 ET	Maxygen to Webcast Second Quarter 2001 Earnings Conference Call On August 14, 2001
Jul 20, 01
09:00 ET	Maxygen Appoints Dr. Ernest Mario to Its Board of Directors
Jul 12, 01
16:00 ET	Maxygen Announces Improved Financial Outlook
May 08, 01
07:00 ET	Maxygen Reports First Quarter 2001 Financial Results
May 03, 01
06:30 ET	Maxygen Announces Achievement of Milestone in Pfizer Collaboration
May 01, 01
20:40 ET	Maxygen
20:39 ET	Maxygen Invites You to Join Its First Quarter Conference Call on the Web
Apr 30, 01
19:49 ET	Maxygen Announces Webcast of Presentation at CIBC World Markets First Annual Biotechnology Investor Conference
Apr 12, 01
07:00 ET	Maxygen Appoints John G. Curd, M.D., Senior Vice President, Clinical Development
Mar 08, 01
20:45 ET	Maxygen Announces Victory in Arbitration With Enchira Biotechnology
Feb 20, 01
06:00 ET	Maxygen and the International AIDS Vaccine Initiative Enter Agreement To Develop Novel Vaccines Against HIV
Feb 13, 01
09:01 ET	Maxygen Reports Fourth Quarter and Year End 2000 Financial Results
Feb 12, 01
16:01 ET	Maxygen Announces New Patent Covering
Feb 08, 01
16:11 ET	Maxygen and ALK-Abello Form $80 Million Strategic Alliance to Develop Next-Generation Allergy Treatments
Feb 07, 01
07:01 ET	Maxygen to Release Fourth Quarter and Year-end 2000 Earnings On February 13, 2001
Jan 29, 01
16:15 ET	Maxygen Announces Issuance of Additional Patent Covering Methods of Gene Recombination Using Single-Stranded Nucleic Acid Templates
Jan 16, 01
09:01 ET	Maxygen Expands Senior Management Team
Jan 09, 01
00:01 ET	Maxygen Announces Issuance of Additional Patents Covering Methods of Producing Chimeric Genes
Dec 21, 00
16:10 ET	Maxygen Takes Additional Product Candidate Into Development
16:05 ET	Maxygen Delivers Lead Agriculture Development Candidate
Dec 12, 00
12:01 ET	Maxygen Announces Conference Call to Discuss Goal Achievement in 2000 And New Corporate Goals for 2001
Dec 07, 00
17:30 ET	Maxygen and Integrated Genomics Announce Collaboration
Nov 14, 00
07:02 ET	Maxygen Reports 2000 Third Quarter Financial Results
Oct 25, 00
23:27 ET	Maxygen Announces Conference Call to Discuss Recent Agreement to Develop New Bulk Chemical Bioprocesses With Chevron
18:56 ET	Maxygen Announces Strategic Agreement to Develop New Bulk Chemical Bioprocesses With Chevron
Oct 18, 00
16:03 ET	Maxygen Awarded Broad Gene Shuffling Patent
Oct 05, 00
07:00 ET	Maxygen Announces Two Year Extension of Collaboration With Pioneer Hi-Bred
Sep 19, 00
09:01 ET	Maxygen Conference Call
09:01 ET	Maxygen and H. Lundbeck A/S Enter Into Research and Development Agreement
Sep 15, 00
05:30 ET	Maxygen and Shearwater Enter Into Strategic Protein Pharmaceutical Alliance
05:30 ET	Maxygen and The Scripps Research Institute Establish Collaboration For Development of Novel HIV Therapies and Vaccines
Sep 13, 00
17:07 ET	Maxygen Awarded Broad Patent Expanding Its Leadership Position in Directed Molecular Evolution
17:04 ET	Maxygen Announces Follow-On Bioprocess Collaboration With Pfizer And Advancement of Product Candidate
Aug 22, 00
06:30 ET	Maxygen Announces Issuance of Patent Covering Preparation of Improved Vectors
Aug 10, 00
22:36 ET	Maxygen Completes Acquisition of ProFound Pharma A/S
Aug 08, 00
16:00 ET	Maxygen Reports 2000 Second Quarter Financial Results
Jul 26, 00
06:30 ET	Maxygen Enters Into Development Program for Allergy Therapeutics With The Karolinska Institute
Jun 13, 00
06:30 ET	Maxygen Announces Advancement Of Additional Product Candidate
Jun 12, 00
06:30 ET	Maxygen and DSM Achieve Research Milestone In Chemical Bioprocess Development Program
May 09, 00
16:08 ET	Maxygen Reports 2000 First Quarter Financial Results
May 05, 00
17:21 ET	Maxygen Announces Promotion of New President
Apr 27, 00
18:01 ET	Maxygen Initiates Arbitration Against Energy BioSystems
Apr 12, 00
17:43 ET	Maxygen to Acquire ProFound Pharma A/S to Expand Its Position in Protein Pharmaceuticals
Mar 21, 00
14:11 ET	Maxygen Prices Follow-On Offering of 1,500,000 Shares of Common Stock
Mar 03, 00
10:14 ET	Maxygen, Inc. Files Registration Statement for Public Offering Of Common Stock
Feb 28, 00
06:30 ET	Maxygen Announces Cooperative Research and Development Agreement With The National Cancer Institute for Novel Protein Pharmaceuticals
Feb 22, 00
17:29 ET	Maxygen Reports Fourth Quarter and Year End 1999 Financial Results
Feb 11, 00
08:00 ET	Maxygen Appoints George Poste to its Board of Directors and Announces Additions to Senior Management
Jan 20, 00
07:31 ET	Maxygen Announces Bioprocess Development Collaboration With Rio Tinto
Dec 22, 99
07:30 ET	Maxygen, Inc. Raises $110 Million in Initial Public Offering of Its Common Stock
Sep 28, 99
07:01 ET	Maxygen Announces $6.7 Million Grant From DARPA to Develop Aerosolized Vaccines
Aug 11, 99
12:56 ET	Maxygen Announces Strategic Partnership with Zeneca Agrochemicals
Jul 14, 99
07:30 ET	Maxygen Raises $20 Million in Private Placement
May 11, 99
07:32 ET	Maxygen Receives Milestone From Pfizer Collaboration
Apr 27, 99
07:31 ET	Maxygen Obtains Exclusive License to Caltech 'StEP' Directed Evolution Technology
Mar 04, 99
06:30 ET	Maxygen and DSM Anti-Infectives Announce Strategic Partnership for Manufacture Of Novel Enzymes
Jan 25, 99
17:47 ET	Maxygen and Pioneer Hi-Bred Announce Strategic AG-Biotech Collaboration
Nov 18, 98
18:55 ET	Maxygen Granted Fundamental U.S. Patents for Methods of Nucleic Acid Recombination
Sep 22, 97
16:25 ET	Maxygen and Novo Nordisk Announce Technology Licensing and Collaboration Agreement
Jun 02, 97
16:25 ET	Zaffaroni Announces New Start-Up Company - Maxygen, Inc.